Background {#Sec1}
==========

Brucellosis is one of the most reported zoonosis worldwide with an emergence of new foci of both human and animal disease related to socio economic changes \[[@CR1]\]. Human-human transmission has occasionally been reported \[[@CR2]\]. Transmission mainly occurs through the ingestion of contaminated raw milk and dairy products, via professional exposure, or via accidental inhalation of the *Brucella* culture \[[@CR3], [@CR4]\]. In human beings the disease is a septicemic febrile illness frequently associated with localized bone and tissue infections \[[@CR5]\]. In animals it causes abortion and fertility problems resulting in considerable financial losses \[[@CR6]\]. Brucellosis occurs widely throughout the world, particularly in developing countries where small ruminants are farmed. The diagnosis of *Brucella* is a challenge, and in low risk countries, the gold standard method used is the microbiological isolation from clinical samples. However, due to its pathogenicity, a biosafety level 3 (BSL-3) laboratory must be used to handle potentially positive samples. *Brucella* infection is one of the major common laboratory-acquired infections in the United States \[[@CR7]\]. In these cases inhalation of infective aerosol is the most common route of transmission, but direct contact with clinical specimens should not be ignored \[[@CR8]\]. Brucellosis is a rare infection in humans in the EU. The highest notification rates and the majority of the autochthonous cases were reported from Mediterranean countries. Brucellosis in livestock has been eradicated in Sweden, but a number of human cases are registered annually from individuals that have travelled in brucellosis risk zones \[[@CR9]\]. Commonly in Sweden, the brucellosis cases are found among travellers returning from endemic countries. Nevertheless, the febrile cases are rarely investigated for brucellosis in the absence of suspected anamnesis. This is the first study in Sweden in which brucellosis is studied in relation to the geographic source. We confirmed the diagnosis and we identified the source of infection for 16 cases of brucellosis detected over a four-year period (2008--2012) by means of PCR typing and MLVA genotyping. Here we applied MLVA in order to understand the geographic origin of the cases, and if there were clusters of infection as a result of food poisoning. Our findings revealed that all 16 cases of human brucellosis in Sweden studied were caused by *B. melitensis* lineages originating from the Middle East and Africa. A paradigmatic case of laboratory-acquired brucellosis (LAB) is also described pointing out the necessity of raising awareness in Sweden for contagious risk in laboratory staff.

Results {#Sec2}
=======

All isolates were initially cultured on sheep blood agar and DNA was prepared using the commercially available EZ1 DNA Tissue kit (Qiagen, Stockholm, Sweden). The *AbortusMelitensisOvisSuis* (AMOS) polymerase chain reaction (PCR) was used for identifying the *Brucella* species, prior to multiplex PCR \[[@CR10], [@CR11]\]. Then isolates were genotyped using the MLVA-16 panel of Le Flèche et al. \[[@CR12]\] with modifications as described by Al Dahouk et al. \[[@CR13]\]. We used the MLVA-16 protocol that uses multiplex PCRs and multicolour capillary electrophoresis \[[@CR14]\], \[[@CR15]\]. The MLVA data of the 16 strains were compared to genotypes from isolates available in the MLVA bank on the website (<http://mlva.u-psud.fr/>). Phylogenetic and cluster analysis was performed using the unweighted pair group method with arithmetic mean (UPGMA) in PAUP\* 4.0b \[[@CR16]\] using the allele data analyzed as alpha codes, aggregating the MLVA data from this study with MLVA data from the East Mediterranean and Africa lineages.

AMOS PCR assigned all the 16 strains to the *B. melitensis* species, which is highly pathogenic to humans. MLVA genotyping identified 14 different genotypes designated with the letters from *A* to *N* (Table [1](#Tab1){ref-type="table"}, Additional file [1](#MOESM1){ref-type="media"}) \[[@CR13], [@CR17], [@CR18]\]. The *B. melitensis* R13_15 strain was cultured from a sample provided by a laboratory trainee (a 38-year-old female) after she began experiencing nonspecific symptoms of malaise. Three months previously she had handled a suspicious sample (later identified as strain R12_209) in a BSL-2 laboratory. No evidence of exposure to brucellosis, other than through occupational exposure, was identified. The epidemiological investigation showed that the trainee performed gram staining while other laboratory staff performed phenotypical tests, but at that time all of them were unaware that they were dealing with *Brucella*. The culture was then sent to the Public Health Agency of Sweden, where *Brucella* was readily identified by culture, real time PCR, and matrix-assisted laser desorption-ionization time-of-flight (MALDI-TOF). The R12_209 strain was isolated from a 65-year-old man with a febrile illness after returning to Sweden from Iraq in October 2012. MLVA linked the strains R13_15 and R12_209 showing a similar genotype (Table [1](#Tab1){ref-type="table"}). Two additional strains R60_09, R68_11 also had similar genotypes and were isolated from patients moved from Kurdistan (Iraq) but in different years without any apparent connection. Interestingly five out of fourteen MLVA-16 genotypes (*A, C, J, K*, and *N*) were previously identified from other authors in patients with recent history of travelling from brucellosis high risk areas. Moreover MLVA searching in the cooperative database of the MLVA bank revealed that the *B. melitensis* R13_6 strain, isolated from a patient moved from Somalia, belonged to the Africa lineage, while the remaining *B. melitensis* strains showed the East Mediterranean lineage for the patients with nationalities from different Middle East countries. The UPGMA clustering method revealed that all the isolates were diverse and widely distributed throughout the *B. melitensis* phylogeny (Fig. [1](#Fig1){ref-type="fig"}). The findings demonstrated a multi foci of infection with potentially different geographic sources.Table 1*Brucella melitensis* isolates studiedStrain idYearPatient nationalitySpeciesLineageMLVA8^a^MLVA11^b^MLVA16CommentsR12_2092012Iraqi*B. melitensis*East Mediterranean43125AExact match with human strains from Germany as introduction from Turkey \[[@CR13]\], and from Turkey \[[@CR18]\]R12_652012Iraqi*B. melitensis*East Mediterranean43NovelBR12_872012Iraqi*B. melitensis*East Mediterranean43125CExact match with human strain from Italy as introduction from Syria \[[@CR14]\]R12_952012Iraqi*B. melitensis*East MediterraneanNovelNovelDR13_152013Swedish*B. melitensis*East Mediterranean43125AExact match with human strains from Germany as introduction from Turkey \[[@CR13]\], and from Turkey \[[@CR18]\]R13_62013Somali*B. melitensis*Africa94178ER14_082008Iraqi*B. melitensis*East Mediterranean43106FR15_082008Syrian*B. melitensis*East Mediterranean43125GR26_102010Iraqi*B. melitensis*East Mediterranean43125HR4_102010Afghan*B. melitensis*East Mediterranean63111IR47_082008Iraqi*B. melitensis*East Mediterranean43125JExact match with human strains from Turkey \[[@CR18]\]R60_092009Kurds*B. melitensis*East Mediterranean43125KExact match with human from Lebanon \[[@CR17]\]R67_082008Kurds*B. melitensis*East Mediterranean43125LR68_112011Kurds*B. melitensis*East Mediterranean43125KExact match with human from Lebanon \[[@CR17]\]R82_112011Iraqi*B. melitensis*East Mediterranean42116MR95_112011Kurds*B. melitensis*East Mediterranean43125NExact match with human strains from Turkey \[[@CR13], [@CR18]\]MLVA profiles are provided as Additional file [1](#MOESM1){ref-type="media"}^a,\ b^ MLVA8 and MLVA11 genotypes are designed according to the *Brucella* cooperative database of the MLVA bank, while MLVA16 genotypes are herein assigned with capital letters (A--N)Fig. 1UPGMA assessment of relationships MLVA-16 profiles for 16 *B. melitensis* isolates from Sweden and 455 *B. melitensis* of West Mediterranean and Africa lineages available from MLVA bank. Swedish isolates are highlighted in *red*, other strains are identified by progressive numbers and geographic source. The branches unrelated are collapsed

In this study we confirm that MLVA continues to demonstrate its effectiveness as a molecular epidemiological tool of bacterial pathogens such as *Brucella* \[[@CR15]\]. The specific level of discrimination offered by VNTRs methodology has put them as gold standard markers in the field of molecular epidemiology. MLVA typing is therefore useful to understand the epidemiological context where the cases are occurring. MLVA has been used to confirm the source of a LAB \[[@CR19]\] as well as to demonstrate the endemicity or distinct clusters of disease \[[@CR15]\]. The genetic fingerprints found demonstrate that the 16 *B. melitensis* isolates reported in this study are linked to Middle East and African areas, in agreement with a previous publication \[[@CR20]\]. Unfortunately, case information is not available for our isolates, but recent immigration or travel from countries with endemic brucellosis might be a common feature for all patients as corroborated by patient nationalities (Table [1](#Tab1){ref-type="table"}). The genetic lineages discovered put the root of the infections in the Middle East and Africa and this reflects the Swedish migration trends of groups from Iraq, Afghanistan and Somalia (source: Statistics Sweden).

Our data demonstrates that in Sweden, human brucellosis may be linked to people with a characteristic anamnesis with recent migration from brucellosis endemic areas. The majority of cases in northern Europe are travel associated. In addition, European countries may also experience domestically acquired cases. These can occur in immigrants from endemic areas or be due to private import of unpasteurized dairy products from endemic areas. Food-borne brucellosis would act as a point cluster disease but the high genetic diversity found would exclude the presence of such food poisoning clusters in our cases.

A laboratory-acquired infection was also traced back by MLVA confirming the suspected epidemiological link between the lab trainee and the brucellosis case. BSL-2 laboratory practices can potentially lead to *Brucella* infections.

It is therefore extremely important to put brucellosis in the differential diagnosis of any acute febrile illness, especially in individuals who have recently moved or travelled from such areas. In those cases, microbiologists working with suspected cases of *Brucella* must follow BSL-3 standards microbiological safety procedures to minimize the risk of infection.

Additional file {#Sec3}
===============

10.1186/s13104-016-2074-7 MLVA profiles for the *B. melitensis* analyzed in this study.
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